Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Zhang, Wei ^a   Xu, Yi Zhi ^b   Liu, Bo ^a   Wu, Rong ^a   Yang, Ying Ying ^a   Xiao, Xiao Qiu ^c   Zhang, Xia ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing the Third Hospital Brief   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN CONVERTING ENZYME 2; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; PIOGLITAZONE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; FATTY LIVER; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; PHYSIOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; FATTY LIVER; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; PEPTIDYL-DIPEPTIDASE A; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; UP-REGULATION;

EID: 84893861975     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/603409     Document Type: Article

References (31)

1. Fan J.-G., Farrell G. C., Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology 2009 50 1 204 210 2-s2.0-56949097660 10.1016/j.jhep.2008.10.010
2. Leite N. C., Villela-Nogueira C. A., Pannain V. L. N., Bottino A. C., Rezende G. F. M., Cardoso C. R. L., Salles G. F., Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver International 2011 31 5 700 706 2-s2.0-79953321393 10.1111/j.1478-3231.2011.02482.x
3. Cohen J. C., Horton J. D., Hobbs H. H., Human fatty liver disease: old questions and new insights. Science 2011 332 6037 1519 1523 2-s2.0-79959517565 10.1126/science.1204265
4. Yki-Järvinen H., Thiazolidinediones and the liver in humans. Current Opinion in Lipidology 2009 20 6 477 483 2-s2.0-73849109435 10.1097/MOL. 0b013e3283321d37
5. Sarafidis P. A., Lasaridis A. N., Nilsson P. M., Pagkalos E. M., Hitoglou-Makedou A. D., Pliakos C. I., Kazakos K. A., Yovos J. G., Zebekakis P. E., Tziolas I. M., Tourkantonis A. N., Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. Journal of Hypertension 2004 22 9 1769 1777 2-s2.0-4344606883 10.1097/00004872-200409000-00022 (Pubitemid 39141970)
6. Rszer T., Ricote M., PPARs in the renal regulation of systemic blood pressure. PPAR Research 2010 2010 11 2-s2.0-77954589084 10.1155/2010/698730 698730
7. Matthew Morris E., Fletcher J. A., Thyfault J. P., The role of angiotensin II in nonalcoholic steatohepatitis. Molecular and Cellular Endocrinology 2013 378 1-2 29 40
8. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R. E., Acton S., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation Research 2000 87 5 E1 E9 2-s2.0-0038053724
9. Santos R. A. S., Simoes e Silva A. C., Maric C., Silva D. M. R., Machado R. P., De Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H.-P., Speth R., Walther T., Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 2-s2.0-0037478671 10.1073/pnas.1432869100 (Pubitemid 36842532)
10. Gao D.-F., Niu X.-L., Hao G.-H., Peng N., Wei J., Ning N., Wang N.-P., Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells-Role of PPAR- γ in vascular fibrosis. Biochemical Pharmacology 2007 73 2 185 197 2-s2.0-33845203576 10.1016/j.bcp.2006.09.019 (Pubitemid 44855720)
11. Paizis G., Tikellis C., Cooper M. E., Schembri J. M., Lew R. A., Smith A. I., Shaw T., Warner F. J., Zuilli A., Burrell L. M., Angus P. W., Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005 54 12 1790 1796 2-s2.0-28144453548 10.1136/gut.2004.062398 (Pubitemid 41697680)
12. Gembardt F., Sterner-Kock A., Imboden H., Spalteholz M., Reibitz F., Schultheiss H.-P., Siems W.-E., Walther T., Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 2005 26 7 1270 1277 2-s2.0-20444407675 10.1016/j.peptides.2005.01.009 (Pubitemid 40798085)
13. Fernandes T., Hashimoto N. Y., Oliveira E. M., Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats. Brazilian Journal of Medical and Biological Research 2010 43 9 837 842 2-s2.0-77957084109 10.1590/S0100-879X2010007500088
14. Gupte M., Boustany-Kari C. M., Bharadwaj K., Police S., Thatcher S., Gong M. C., English V. L., Cassis L. A., ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2008 295 3 R781 R788 2-s2.0-54049109974 10.1152/ajpregu.00183.2008
15. Lee M. Y., Lee E. Y., Lee B. J., Won C. S., Koh J. H., Shin J. Y., Shin Y. G., Cho B. P., Chung C. H., Beneficial effects of thiazolidinediones on diabetic nephropathy in OLETF rats. Yonsei Medical Journal 2007 48 2 301 307 2-s2.0-34248151914 10.3349/ymj.2007.48.2.301 (Pubitemid 46711763)
16. Kleiner D. E., Brunt E. M., van Natta M., Behling C., Contos M. J., Cummings O. W., Ferrell L. D., Liu Y.-C., Torbenson M. S., Unalp-Arida A., Yeh M., McCullough A. J., Sanyal A. J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005 41 6 1313 1321 2-s2.0-20044374023 10.1002/hep.20701 (Pubitemid 40770284)
17. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
18. Xu Z.-J., Fan J.-G., Ding X.-D., Qiao L., Wang G.-L., Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Digestive Diseases and Sciences 2010 55 4 931 940 2-s2.0-77950355485 10.1007/s10620-009-0815-3
19. Kliewer S. A., Sundseth S. S., Jones S. A., Brown P. J., Wisely G. B., Koble C. S., Devchand P., Wahli W., Willson T. M., Lenhard J. M., Lehmann J. M., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4318 4323 2-s2.0-0006132932 10.1073/pnas.94.9.4318 (Pubitemid 27194239)
20. Herath C. B., Warner F. J., Lubel J. S., Dean R. G., Jia Z., Lew R. A., Smith A. I., Burrell L. M., Angus P. W., Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. Journal of Hepatology 2007 47 3 387 395 2-s2.0-34547410910 10.1016/j.jhep.2007.03.008 (Pubitemid 47176156)
21. Boustany C. M., Bharadwaj K., Daugherty A., Brown D. R., Randall D. C., Cassis L. A., Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2004 287 4 R943 R949 2-s2.0-4644307190 10.1152/ajpregu.00265.2004 (Pubitemid 39280483)
22. Rahmouni K., Mark A. L., Haynes W. G., Sigmund C. D., Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. American Journal of Physiology-Endocrinology and Metabolism 2004 286 6 E891 E895 2-s2.0-2442646800 10.1152/ajpendo.00551.2003 (Pubitemid 38668809)
23. Engeli S., Böhnke J., Gorzelniak K., Janke J., Schling P., Bader M., Luft F. C., Sharma A. M., Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005 45 3 356 362 2-s2.0-14644395574 10.1161/01.HYP. 0000154361.47683.d3 (Pubitemid 40315803)
24. Bertile F., Raclot T., Differences in mRNA expression of adipocyte-derived factors in response to fasting, refeeding and leptin. Biochimica et Biophysica Acta 2004 1683 1-3 101 109 2-s2.0-3042611839 10.1016/j.bbalip.2004.05.001 (Pubitemid 38844664)
25. Einstein F. H., Atzmon G., Yang X.-M., Ma X.-H., Rincon M., Rudin E., Muzumdar R., Barzilai N., Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 2005 54 3 672 678 2-s2.0-14644417152 10.2337/diabetes.54.3.672 (Pubitemid 40322069)
26. Mayerson A. B., Hundal R. S., Dufour S., Lebon V., Befroy D., Cline G. W., Enocksson S., Inzucchi S. E., Shulman G. I., Petersen K. F., The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 2002 51 3 797 802 2-s2.0-0036310037 (Pubitemid 34760191)
27. Huang M.-L., Li X., Meng Y., Xiao B., Ma Q., Ying S.-S., Wu P.-S., Zhang Z.-S., Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clinical and Experimental Pharmacology and Physiology 2010 37 1 e1 e6 2-s2.0-74049134978 10.1111/j.1440-1681.2009.05302.x
28. Ferrario C. M., Jessup J., Chappell M. C., Averill D. B., Brosnihan K. B., Tallant E. A., Diz D. I., Gallagher P. E., Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005 111 20 2605 2610 2-s2.0-19644384705 10.1161/CIRCULATIONAHA.104.510461 (Pubitemid 40740859)
29. Zhang X., Li Z.-Z., Liu D.-F., Xu X., Mei Z.-C., Shen W., Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor- α interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes. Clinical and Experimental Pharmacology and Physiology 2009 36 7 631 636 2-s2.0-67650721353 10.1111/j.1440-1681.2008. 05129.x
30. Georgescu E. F., Ionescu R., Niculescu M., Mogoanta L., Vancica L., Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis. World Journal of Gastroenterology 2009 15 8 942 954 2-s2.0-65649112801 10.3748/wjg.15.942
31. Olivares-Reyes J. A., Arellano-Plancarte A., Castillo-Hernandez J. R., Angiotensin II and the development of insulin resistance: implications for diabetes. Molecular and Cellular Endocrinology 2009 302 2 128 139 2-s2.0-63149193315 10.1016/j.mce.2008.12.011